HQC:
RECOVERY (RCT) -9% 1.09 [0.97-1.23] death 421/1,561 790/3,155
Mitjà (RCT) 52% 0.48 [0.15-1.57] death 4/1,196 9/1,301
SOLIDARITY (RCT) -19% 1.19 [0.89-1.59] death 104/947 84/906
---
Ivermectin:
Seet (CLUS. RCT) 50% 0.50 [0.33-0.76] severe case 32/617 64/619 12mg
Elgazzar (RCT) 92% 0.08 [0.02-0.35] death 2/200 24/200 112mg
Mahmud (DB RCT) 86% 0.14 [0.01-2.75] death 0/183 3/183 12mg
---
My guess is: HCQ was very promising in early 2020 and there has been enough time to make big RCT. Ivermectin got more promising this year and the big RCT didn't finish yet, or the results are still not published.
(In a big trial with a few thousand patients, you need a lot of time, coordination and paperwork, so the result is less likely to not get published.)